|
|
|
|
|
|
Companies > Commercial
|
|
|
NeoProteomics seeks to identify and validate biomarkers of human disease through advanced proteomic analysis. As an early source of revenue, the Company will also conduct computational proteomic analytical services for academic institutions and strategic corporate partners. Markets of interest include colon cancer, diabetic complications and both osteo- and rheumatoid arthritis.
Funders:
Strategic Partner
|
|
|
|
|